Can-Fite Biopharma Ltd (CANF)
CANF trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.95
0.00% on the day
Market cap
$5.9M
Nano cap
Revenue · 2025
$405K
-39.9% on 2024
Net income · 2025
-$9.8M
-2426.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CANF on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001536196 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $405K |
| Net income | -$9.8M |
| Operating income | -$9.9M |
| Net margin | -2426.7% |
| Operating margin | -2456.8% |
| Revenue growth | -39.9% |
| Cash | $5.5M |
| Total assets | $9.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 14.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-10-09 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-03-26 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-09 |
Source: SEC EDGAR submissions feed, 863 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | $2.80 | -14.37% | $5.9M |
| MDCX | Medicus Pharma Ltd. Common Stock | $3.28 | -8.38% | $5.9M |
| IMNN | Imunon Inc. | $1.07 | 0.00% | $6.0M |
| BGMS | Bio Green Med Solution Inc. | $0.9199 | -7.08% | $6.1M |
| ENVB | Enveric Biosciences Inc. | $1.40 | -4.76% | $6.3M |
| TRAW | Traws Pharma Inc. | $0.4101 | -1.42% | $6.3M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier